Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:affects |
lungs
multiple organs |
| gptkbp:associatedWith |
gptkb:SARS-CoV-2_infection
|
| gptkbp:cause |
gptkb:arrhythmia
gptkb:long_COVID death shock stroke pulmonary embolism delirium secondary infections myocarditis acute kidney injury cardiac complications liver injury coagulopathy neurological complications kidney injury permanent lung damage |
| gptkbp:causedBy |
gptkb:COVID-19
|
| gptkbp:complication |
gptkb:acute_respiratory_distress_syndrome
sepsis multi-organ failure thromboembolism |
| gptkbp:diagnosedBy |
PCR test
chest imaging |
| gptkbp:firstReported |
2019
|
| gptkbp:hospitalizationRequired |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 (severe cases)
|
| gptkbp:ICUAdmissionRequired |
sometimes
|
| gptkbp:mortalityRate |
higher than mild cases
|
| gptkbp:prevention |
gptkb:COVID-19_vaccination
social distancing mask wearing hand hygiene |
| gptkbp:riskFactor |
gptkb:cardiovascular_disease
gptkb:diabetes immunosuppression older age chronic lung disease |
| gptkbp:symptom |
confusion
shortness of breath chest pain bluish lips or face |
| gptkbp:treatment |
antiviral drugs
oxygen therapy corticosteroids mechanical ventilation |
| gptkbp:bfsParent |
gptkb:tocilizumab
gptkb:Actemra |
| gptkbp:bfsLayer |
7
|